Ann Hanham - Net Worth and Insider Trading

Ann Hanham Net Worth

The estimated net worth of Ann Hanham is at least $17 Million dollars as of 2024-11-10. Ann Hanham is the Director of Endocyte Inc and owns about 705,435 shares of Endocyte Inc (ECYT) stock worth over $17 Million. Ann Hanham is also the Director of SCYNEXIS Inc and owns about 3,622 shares of SCYNEXIS Inc (SCYX) stock worth over $4,745. Details can be seen in Ann Hanham's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ann Hanham has not made any transactions after 2020-12-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Ann Hanham

To

Ann Hanham Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ann Hanham owns 4 companies in total, including HTG Molecular Diagnostics Inc (HTGMQ) , SCYNEXIS Inc (SCYX) , and Endocyte Inc (ECYT) among others .

Click here to see the complete history of Ann Hanham’s form 4 insider trades.

Insider Ownership Summary of Ann Hanham

Ticker Comapny Transaction Date Type of Owner
HTGMQ HTG Molecular Diagnostics Inc 2016-08-25 director
SCYX SCYNEXIS Inc 2023-06-15 director
ECYT Endocyte Inc 2017-05-04 director
LIMIT LIMIT 2006-04-11 director

Ann Hanham Latest Holdings Summary

Ann Hanham currently owns a total of 2 stocks. Among these stocks, Ann Hanham owns 705,435 shares of Endocyte Inc (ECYT) as of May 28, 2013, with a value of $17 Million and a weighting of 99.97%. Ann Hanham also owns 3,622 shares of SCYNEXIS Inc (SCYX) as of December 21, 2020, with a value of $4,745 and a weighting of 0.03%.

Latest Holdings of Ann Hanham

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ECYT Endocyte Inc 2013-05-28 705,435 23.99 16,923,386
SCYX SCYNEXIS Inc 2020-12-21 3,622 1.31 4,745

Holding Weightings of Ann Hanham


Ann Hanham Form 4 Trading Tracker

According to the SEC Form 4 filings, Ann Hanham has made a total of 0 transactions in Endocyte Inc (ECYT) over the past 5 years. The most-recent trade in Endocyte Inc is the sale of 9,900 shares on May 28, 2013, which brought Ann Hanham around $139,590.

According to the SEC Form 4 filings, Ann Hanham has made a total of 1 transactions in SCYNEXIS Inc (SCYX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in SCYNEXIS Inc is the acquisition of 3,200 shares on December 21, 2020, which cost Ann Hanham around $20,000.

Insider Trading History of Ann Hanham

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ann Hanham Trading Performance

GuruFocus tracks the stock performance after each of Ann Hanham's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ann Hanham is 10.05%. GuruFocus also compares Ann Hanham's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ann Hanham within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Ann Hanham's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Ann Hanham

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -7.67 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -8.54 LIMIT LIMIT LIMIT LIMIT LIMIT

Ann Hanham Ownership Network

Ownership Network List of Ann Hanham

No Data

Ownership Network Relation of Ann Hanham

Insider Network Chart

Ann Hanham Owned Company Details

What does HTG Molecular Diagnostics Inc do?

Who are the key executives at HTG Molecular Diagnostics Inc?

Ann Hanham is the director of HTG Molecular Diagnostics Inc. Other key executives at HTG Molecular Diagnostics Inc include Senior VP of Therapeutics Stephen Barat , 10 percent owner L5 Capital Inc. , and SVP/Chief Commercial Officer Byron Lawson .

HTG Molecular Diagnostics Inc (HTGMQ) Insider Trades Summary

Over the past 18 months, Ann Hanham made no insider transaction in HTG Molecular Diagnostics Inc (HTGMQ). Other recent insider transactions involving HTG Molecular Diagnostics Inc (HTGMQ) include a net sale of 888 shares made by Stephen Barat ,

In summary, during the past 3 months, insiders sold 0 shares of HTG Molecular Diagnostics Inc (HTGMQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 888 shares of HTG Molecular Diagnostics Inc (HTGMQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 888 shares.

HTG Molecular Diagnostics Inc (HTGMQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

HTG Molecular Diagnostics Inc Insider Transactions

No Available Data

Ann Hanham Mailing Address

Above is the net worth, insider trading, and ownership report for Ann Hanham. You might contact Ann Hanham via mailing address: One Embracadero Ctr, Ste 2700, San Francisco Ca 94111.